Literature DB >> 28826559

Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.

Ravneet Vohra1, Abhinandan Batra2, Sean C Forbes2, Krista Vandenborne2, Glenn A Walter3.   

Abstract

Genetic modifiers alter disease progression in both preclinical models and subjects with Duchenne muscular dystrophy (DMD). Using multiparametric magnetic resonance (MR) techniques, we compared the skeletal and cardiac muscles of two different dystrophic mouse models of DMD, which are on different genetic backgrounds, the C57BL/10ScSn-Dmdmdx (B10-mdx) and D2.B10-Dmdmdx (D2-mdx). The proton transverse relaxation constant (T2) using both MR imaging and spectroscopy revealed significant age-related differences in dystrophic skeletal and cardiac muscles as compared with their age-matched controls. D2-mdx muscles demonstrated an earlier and accelerated decrease in muscle T2 compared with age-matched B10-mdx muscles. Diffusion-weighted MR imaging indicated differences in the underlying muscle structure between the mouse strains. The fractional anisotropy, mean diffusion, and radial diffusion of water varied significantly between the two dystrophic strains. Muscle structural differences were confirmed by histological analyses of the gastrocnemius, revealing a decreased muscle fiber size and increased fibrosis in skeletal muscle fibers of D2-mdx mice compared with B10-mdx and control. Cardiac involvement was also detected in D2-mdx myocardium based on both decreased function and myocardial T2. These data indicate that MR parameters may be used as sensitive biomarkers to detect fibrotic tissue deposition and fiber atrophy in dystrophic strains.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28826559      PMCID: PMC5809503          DOI: 10.1016/j.ajpath.2017.05.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  77 in total

1.  Diffusive sensitivity to muscle architecture: a magnetic resonance diffusion tensor imaging study of the human calf.

Authors:  Craig J Galbán; Stefan Maderwald; Kai Uffmann; Armin de Greiff; Mark E Ladd
Journal:  Eur J Appl Physiol       Date:  2004-12       Impact factor: 3.078

2.  Histopathological changes in Duchenne muscular dystrophy.

Authors:  C D Bell; P E Conen
Journal:  J Neurol Sci       Date:  1968 Nov-Dec       Impact factor: 3.181

3.  Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.

Authors:  Wei Li; Wei Liu; Jia Zhong; Xin Yu
Journal:  J Cardiovasc Magn Reson       Date:  2009-10-22       Impact factor: 5.364

4.  Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy.

Authors:  Jiangyang Zhang; Gang Zhang; Brett Morrison; Susumu Mori; Kazim A Sheikh
Journal:  Exp Neurol       Date:  2008-05-10       Impact factor: 5.330

5.  Utrophin localization in normal and dystrophin-deficient heart.

Authors:  F Pons; A Robert; E Fabbrizio; G Hugon; J C Califano; J A Fehrentz; J Martinez; D Mornet
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

6.  Further impairment of muscle phosphate kinetics by lengthening exercise in DMD/BMD carriers. An in vivo 31P-NMR spectroscopy study.

Authors:  B Barbiroli; K K McCully; S Iotti; R Lodi; P Zaniol; B Chance
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

7.  Diffusion tensor MRI to assess damage in healthy and dystrophic skeletal muscle after lengthening contractions.

Authors:  Alan B McMillan; Da Shi; Stephen J P Pratt; Richard M Lovering
Journal:  J Biomed Biotechnol       Date:  2011-11-15

8.  Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.

Authors:  Joshua Park; Jacqueline Wicki; Sue E Knoblaugh; Jeffrey S Chamberlain; Donghoon Lee
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

9.  Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.

Authors:  Sean C Forbes; Rebecca J Willcocks; William T Triplett; William D Rooney; Donovan J Lott; Dah-Jyuu Wang; Jim Pollaro; Claudia R Senesac; Michael J Daniels; Richard S Finkel; Barry S Russman; Barry J Byrne; Erika L Finanger; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

10.  Diffusion in hierarchical systems: A simulation study in models of healthy and diseased muscle tissue.

Authors:  Matt G Hall; Chris A Clark
Journal:  Magn Reson Med       Date:  2016-09-25       Impact factor: 4.668

View more
  12 in total

1.  MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.

Authors:  Sarah M Judge; Michael R Deyhle; Daria Neyroud; Rachel L Nosacka; Andrew C D'Lugos; Miles E Cameron; Ravneet S Vohra; Ashley J Smuder; Brandon M Roberts; Chandler S Callaway; Patrick W Underwood; Stephen M Chrzanowski; Abhinandan Batra; Meghan E Murphy; Jonathan D Heaven; Glenn A Walter; Jose G Trevino; Andrew R Judge
Journal:  Cancer Res       Date:  2020-03-04       Impact factor: 12.701

Review 2.  Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.

Authors:  Justin R Fallon; Elizabeth M McNally
Journal:  Matrix Biol       Date:  2018-02-23       Impact factor: 11.583

3.  Increased tumour burden alters skeletal muscle properties in the KPC mouse model of pancreatic cancer.

Authors:  Ravneet Vohra; Matthew D Campbell; Joshua Park; Stella Whang; Kayla Gravelle; Yak-Nam Wang; Joo-Ha Hwang; David J Marcinek; Donghoon Lee
Journal:  JCSM Rapid Commun       Date:  2020-06-07

4.  "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.

Authors:  Heather Gordish-Dressman; Raffaella Willmann; Laura Dalle Pazze; Arati Kreibich; Maaike van Putten; Ahlke Heydemann; Laurent Bogdanik; Cathleen Lutz; Kay Davies; Alexis R Demonbreun; Dongsheng Duan; David Elsey; So-Ichiro Fukada; Mahasweta Girgenrath; J Patrick Gonzalez; Miranda D Grounds; Andy Nichols; Terry Partridge; Marco Passini; Francesca Sanarica; Frederick J Schnell; Dominic J Wells; Toshifumi Yokota; Courtney S Young; Zhong Zhong; Christopher Spurney; Melissa Spencer; Annamaria De Luca; Kanneboyina Nagaraju; Annemieke Aartsma-Rus
Journal:  J Neuromuscul Dis       Date:  2018

5.  Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice.

Authors:  Tahnee L Kennedy; Simon Guiraud; Ben Edwards; Sarah Squire; Lee Moir; Arran Babbs; Guy Odom; Diane Golebiowski; Joel Schneider; Jeffrey S Chamberlain; Kay E Davies
Journal:  Mol Ther Methods Clin Dev       Date:  2018-10-16       Impact factor: 6.698

6.  Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy.

Authors:  Maaike van Putten; Kayleigh Putker; Maurice Overzier; W A Adamzek; Svetlana Pasteuning-Vuhman; Jaap J Plomp; Annemieke Aartsma-Rus
Journal:  FASEB J       Date:  2019-04-01       Impact factor: 5.191

7.  A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Davy van de Vijver; Joke W Boertje-van der Meulen; Kayleigh Putker; Kevin Adamzek; Annemieke Aartsma-Rus; Maaike van Putten
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

8.  Plasma lipidomic analysis shows a disease progression signature in mdx mice.

Authors:  Roula Tsonaka; Alexandre Seyer; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  Use of EP3533-Enhanced Magnetic Resonance Imaging as a Measure of Disease Progression in Skeletal Muscle of mdx Mice.

Authors:  Alexander Peter Murphy; Elizabeth Greally; Dara O'Hogain; Andrew Blamire; Peter Caravan; Volker Straub
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

10.  Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice.

Authors:  Nicole A Datson; Suzanne Bijl; Anneke Janson; Janwillem Testerink; Rani van den Eijnde; Rudie Weij; Jukka Puoliväli; Kimmo Lehtimäki; Timo Bragge; Toni Ahtoniemi; Judith C van Deutekom
Journal:  Nucleic Acid Ther       Date:  2019-12-10       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.